- Home
- SOPA vs TCBP Comparison
SOPA vs TCBP Comparison
Compare SOPA & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- TCBP
- Stock Information
- Founded
- SOPA 2018
- TCBP 2013
- Country
- SOPA Singapore
- TCBP United Kingdom
- Employees
- SOPA N/A
- TCBP N/A
- Industry
- SOPA EDP Services
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOPA Technology
- TCBP Health Care
- Exchange
- SOPA Nasdaq
- TCBP Nasdaq
- Market Cap
- SOPA 2.9M
- TCBP 3.0M
- IPO Year
- SOPA 2021
- TCBP 2022
- Fundamental
- Price
- SOPA $0.96
- TCBP $0.68
- Analyst Decision
- SOPA Buy
- TCBP
- Analyst Count
- SOPA 2
- TCBP 0
- Target Price
- SOPA $19.00
- TCBP N/A
- AVG Volume (30 Days)
- SOPA 39.5K
- TCBP 3.0M
- Earning Date
- SOPA 11-22-2024
- TCBP 11-29-2024
- Dividend Yield
- SOPA N/A
- TCBP N/A
- EPS Growth
- SOPA N/A
- TCBP N/A
- EPS
- SOPA N/A
- TCBP N/A
- Revenue
- SOPA $6,906,240.00
- TCBP N/A
- Revenue This Year
- SOPA $14.21
- TCBP N/A
- Revenue Next Year
- SOPA $98.91
- TCBP N/A
- P/E Ratio
- SOPA N/A
- TCBP N/A
- Revenue Growth
- SOPA N/A
- TCBP N/A
- 52 Week Low
- SOPA $0.73
- TCBP $0.56
- 52 Week High
- SOPA $5.10
- TCBP $138.00
- Technical
- Relative Strength Index (RSI)
- SOPA 49.30
- TCBP 23.01
- Support Level
- SOPA $0.91
- TCBP $1.05
- Resistance Level
- SOPA $0.97
- TCBP $1.25
- Average True Range (ATR)
- SOPA 0.05
- TCBP 0.22
- MACD
- SOPA 0.00
- TCBP 0.06
- Stochastic Oscillator
- SOPA 47.92
- TCBP 10.36
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.